# Kaiser Permanente Ventures

Kaiser Permanente Ventures is a Venture Capital based in Oakland, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Oakland, United States
- **Region:** North America
- **Address:** Oakland, CA, United States
- **Founded:** 1997
- **Assets under management:** Undisclosed
- **Website:** www.kpventures.com
- **LinkedIn:** https://www.linkedin.com/company/kaiser-permanente-ventures-llc

## Regulatory record

- **Reports private funds:** No

## About

Kaiser Permanente Ventures is a healthcare venture investing firm that partners with entrepreneurs to build great companies. It makes investments in promising healthcare companies targeting areas of real need, focusing on solutions that provide clear value for patients, providers, healthcare delivery systems and the larger community.

## Sectors

- Digital Health
- Healthcare Services
- Enterprise Software
- AI/ML

## People

- Liz Rockett — Managing Director

## Questions

### Who runs investment decisions at Kaiser Permanente Ventures?

Liz Rockett, Managing Director, has led the firm since 2013. She joined from a healthcare growth equity background and oversees a lean investment team. All investment decisions are made internally by the KP Ventures team, with input from Kaiser's clinical and operational leaders. Rockett reports into Kaiser's broader finance and strategy organization.

### How does Kaiser Permanente Ventures source proprietary deal flow?

The firm sources through Kaiser's clinical network, physician referrals, and relationships with health-tech entrepreneurs. Because the firm can offer pilot-program access inside a 12.7-million-member system, many founders approach KP Ventures early. The clinical validation pathway acts as a sourcing magnet.

### Which sectors does Kaiser Permanente Ventures explicitly avoid?

KP Ventures does not publicly maintain a formal exclusion list. In practice, the firm avoids therapeutics, biopharma, and medical devices that lack a clear line of sight to integration with Kaiser's care-delivery model. The focus stays on digital health, healthcare IT, services, and select diagnostics.

### How does KP Ventures interact with Kaiser Permanente's clinical operations?

The firm functions as a bridge between startups and Kaiser's medical groups. Portfolio companies can access de-identified clinical data, physician feedback, and pilot programs inside Kaiser hospitals. This operational integration is the core differentiator — the firm is not a passive financial investor.

### Has KP Ventures produced any notable exits?

Yes. Livongo Health, a digital chronic disease management company that KP Ventures backed, was acquired by Teladoc for $18.5 billion in 2020. Health Catalyst, another portfolio company, went public in 2019. Both exits validated the firm's thesis of investing in companies that align with value-based, integrated care models.

## Related profiles

- [Kaisa Shijia Equity Investment Management](https://altss.com/profile/kaisa-shijia-equity-investment-management)
- [KAIST Ventures](https://altss.com/profile/kaist-ventures)

---

Last updated: 2026-08-11T15:07:12.582Z

Canonical page: https://altss.com/profile/kaiser-permanente-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology